Bromocriptine
Indication
Parkinson's disease
MHRA Drug Safety Update - Ergot-derived dopamine agonists: risk of fibrotic reactions
Amber level 0
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: